| | Males | P value | Females | P value |
|---|
OR (95%CI) | OR (95%CI) |
|---|
Trans-DCCA |
Detection rate (%) | 9.03 | | 14.25 | |
Model 1 | 1.83 (0.57–5.94) | 0.307 | 0.42 (0.14–1.31) | 0.132 |
Model 2 | 1.85 (0.56–6.10) | 0.307 | 0.36 (0.11–1.25) | 0.107 |
Model 3 | 2.23 (0.75–6.62) | 0.146 | 0.28 (0.06–1.21) | 0.086 |
4-F-3PBA |
Detection rate (%) | 6.48 | | 8.67 | |
Model 1 | 3.91(1.17–13.10) | 0.028 | 1.30 (0.38–4.43) | 0.672 |
Model 2 | 3.82 (1.12–13.00) | 0.032 | 1.53 (0.48–4.88) | 0.469 |
Model 3 | 4.40 (1.32–14.58) | 0.016 | 1.25 (0.36–4.35) | 0.726 |
- OR: odds ratio; CI: confidence interval
- Metabolites were dichotomized as detected vs. undetected, and the undetected group was treated as a reference
- Model 1: Adjusted for urinary creatinine
- Model 2: Adjusted for age, race/ethnicity, and urinary creatinine
- Model 3: Adjusted for age, race/ethnicity, urinary creatinine, the ratio of family income to poverty, physical activity, and body mass index.3-PBA: 3-Phenoxybenzoic Acid; NHANES: National Health and Nutrition Examination Survey; BMI: Body Mass Index; PIR: Poverty Income Ratio; Trans-DCCA: Trans-3-(2,2-Dichlorovinyl)-2,2-Dimethylcylopropane Carboxylic Acid; 4-F-3-PBA: 4-Fluoro-3-Phenoxy-Benzoic Acid; Cis-DBCA: Cis-(2,2-Dibromovinyl)-2,2-Dimethylcyclopropane-1-Carboxylic Acid; CI: Confidence Interval; OR: Odds Ratio
